News from Ambrx, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 17, 2016, 05:00 ET Ambrx's Innovative Antibody Drug Conjugate (ADC) US IND Active

Ambrx announced today that their ARX788 US IND is now active. ARX788 is Ambrx's most advanced internally developed site-specific ADC targeting...


Aug 04, 2016, 09:00 ET Ambrx closes $45M round of financing

 Ambrx, Inc., a clinical stage biotechnology company that discovers and develops first-in-class and best-in-class optimized protein...


Nov 16, 2015, 10:22 ET Ambrx Announces New Chief Medical Officer

 Ambrx today announced the appointment of Yong-Jiang Hei, M.D., Ph.D. as Chief Medical Officer (CMO) reporting directly to CEO, Tiecheng "Alex"...


Jul 24, 2007, 01:00 ET Ambrx Appoints Stephen Kaldor Chief Executive Officer

SAN DIEGO, July 24 /PRNewswire/ -- Ambrx, Inc., today announced the appointment of Stephen Kaldor, Ph.D., as President and Chief Executive...


Feb 12, 2007, 00:00 ET Ambrx Initiates Phase I/II Clinical Trial of Novel Human Growth Hormone Product Candidate

SAN DIEGO, Feb. 12 /PRNewswire/ -- Ambrx, Inc., announced today that it has initiated a Phase I/II clinical trial of ARX201, a novel,...


Sep 20, 2005, 01:00 ET Ambrx Appoints Martin A. Mattingly as President and CEO

SAN DIEGO, Sept. 20 /PRNewswire/ -- Ambrx, Inc., announced today the appointment of Martin A Mattingly, Pharm.D. as President and Chief...


Apr 13, 2005, 01:00 ET Ambrx Appoints Dr. August Watanabe to Board of Directors

SAN DIEGO, April 13 /PRNewswire/ -- Ambrx, Inc., today announced the appointment of August M. Watanabe, M.D. to its Board of Directors. Dr....


Apr 08, 2005, 01:00 ET Ambrx Completes $23.4 Million Private Placement

SAN DIEGO, April 8 /PRNewswire/ -- Ambrx, Inc., today announced the completion of a $23.4 million preferred stock financing. The funds will be...


Apr 06, 2005, 01:00 ET Ambrx Appoints Bruce Kimmel, Ph.D. as Vice President, Therapeutic Applications

SAN DIEGO, April 6 /PRNewswire/ -- Ambrx, Inc., announced today the appointment of Bruce Kimmel, Ph.D. as Vice President, Therapeutic...


Sep 22, 2003, 01:00 ET Ambrx Assembles World Class Team and Raises $12.5 Million to Apply Breakthrough Technology to Protein Therapeutics

SAN DIEGO, Sept. 22 /PRNewswire/ -- Ambrx, Inc., a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics,...